Interpace Biosciences Inc Capitalisation boursière
Quel est le Capitalisation boursière de Interpace Biosciences Inc?
Le Capitalisation boursière de Interpace Biosciences Inc est $4.48M
Quelle est la définition de Capitalisation boursière?
La capitalisation boursière est la valeur marchande à un moment donné des actions en circulation d'une société cotée en bourse, étant égale au cours de l' action à ce moment-là, multiplié par le nombre d'actions en circulation .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Capitalisation boursière des entreprises dans Health Care secteur sur NASDAQ par rapport à Interpace Biosciences Inc
Que fait Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Entreprises avec capitalisation boursière similaire à Interpace Biosciences Inc
- Ragnar Metals a Capitalisation boursière de $4.47M
- Sacheta Metals a Capitalisation boursière de $4.47M
- Ignite a Capitalisation boursière de $4.47M
- The Ravalgaon Sugar Farm a Capitalisation boursière de $4.47M
- Emperor a Capitalisation boursière de $4.48M
- Eros Resources a Capitalisation boursière de $4.48M
- Interpace Biosciences Inc a Capitalisation boursière de $4.48M
- Prakash Woollen & Synthetic Mills a Capitalisation boursière de $4.48M
- Elys Game Technology a Capitalisation boursière de $4.48M
- Yorkton Ventures a Capitalisation boursière de $4.48M
- Chi Ho Development a Capitalisation boursière de $4.48M
- Polychem a Capitalisation boursière de $4.49M
- NuLegacy Gold a Capitalisation boursière de $4.49M